Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation.
Saved in:
| Title: | Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation. |
|---|---|
| Authors: | Illamola SM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States., Bhongsatiern JJ; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States.; Quantitative Pharmacology, Regeneron Pharmaceuticals, Tarrytown, NY, United States., Birnbaum AK; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States., Kumar SS; Clinical Pharmacology Modeling Simulation, Parexel International, Sydney, NSW, Australia., Courter JD; Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Haslam DB; Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Allegaert K; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands., Reith DM; Office of the Dean, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Desai PB; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States., Sherwin CM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.; Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States.; Internal Medicine, UWA Medical School, The University of Western Australia, Perth, WA, Australia.; Clinical Pharmacology and Pharmacometrics, Differentia Biotech Ltd., San Francisco, CA, United States. |
| Source: | Frontiers in antibiotics [Front Antibiot] 2025 May 08; Vol. 4, pp. 1568931. Date of Electronic Publication: 2025 May 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918557185706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-2467 (Electronic) Linking ISSN: 28132467 NLM ISO Abbreviation: Front Antibiot Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40406542 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Illamola+SM%22">Illamola SM</searchLink>; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.<br /><searchLink fieldCode="AU" term="%22Bhongsatiern+JJ%22">Bhongsatiern JJ</searchLink>; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States.; Quantitative Pharmacology, Regeneron Pharmaceuticals, Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Birnbaum+AK%22">Birnbaum AK</searchLink>; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Kumar+SS%22">Kumar SS</searchLink>; Clinical Pharmacology Modeling Simulation, Parexel International, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Courter+JD%22">Courter JD</searchLink>; Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.<br /><searchLink fieldCode="AU" term="%22Haslam+DB%22">Haslam DB</searchLink>; Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.<br /><searchLink fieldCode="AU" term="%22Allegaert+K%22">Allegaert K</searchLink>; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Reith+DM%22">Reith DM</searchLink>; Office of the Dean, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Desai+PB%22">Desai PB</searchLink>; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States.<br /><searchLink fieldCode="AU" term="%22Sherwin+CM%22">Sherwin CM</searchLink>; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.; Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States.; Internal Medicine, UWA Medical School, The University of Western Australia, Perth, WA, Australia.; Clinical Pharmacology and Pharmacometrics, Differentia Biotech Ltd., San Francisco, CA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918557185706676%22">Frontiers in antibiotics</searchLink> [Front Antibiot] 2025 May 08; Vol. 4, pp. 1568931. <i>Date of Electronic Publication: </i>2025 May 08 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918557185706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2813-2467 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2228132467%22">28132467 </searchLink><i>NLM ISO Abbreviation: </i>Front Antibiot <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40406542 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/frabi.2025.1568931 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1568931 Titles: – TitleFull: Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Illamola SM – PersonEntity: Name: NameFull: Bhongsatiern JJ – PersonEntity: Name: NameFull: Birnbaum AK – PersonEntity: Name: NameFull: Kumar SS – PersonEntity: Name: NameFull: Courter JD – PersonEntity: Name: NameFull: Haslam DB – PersonEntity: Name: NameFull: Allegaert K – PersonEntity: Name: NameFull: Reith DM – PersonEntity: Name: NameFull: Desai PB – PersonEntity: Name: NameFull: Sherwin CM IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2025 May 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2813-2467 Numbering: – Type: volume Value: 4 Titles: – TitleFull: Frontiers in antibiotics Type: main |
| ResultId | 1 |